These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
751 related items for PubMed ID: 22059858
1. Ocular pharmacokinetics profile of different indomethacin topical formulations. Bucolo C, Melilli B, Piazza C, Zurria M, Drago F. J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858 [Abstract] [Full Text] [Related]
4. Vitreous and aqueous penetration of orally and topically administered moxifloxacin. Fukuda M, Shibata N, Osada H, Yamashiro Y, Sasaki H. Ophthalmic Res; 2011 Dec; 46(3):113-7. PubMed ID: 21325873 [Abstract] [Full Text] [Related]
5. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery]. Hessemer V, Schmitt K, Jacobi A. Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774 [Abstract] [Full Text] [Related]
6. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration. Yuan J, Zhai JJ, Chen JQ, Ye CT, Zhou SY. J Ocul Pharmacol Ther; 2009 Aug; 25(4):345-50. PubMed ID: 19492954 [Abstract] [Full Text] [Related]
7. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits. Iyer GR, Cason MM, Womble SW, Li G, Chastain JE. J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192 [Abstract] [Full Text] [Related]
8. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. Proksch JW, Granvil CP, Siou-Mermet R, Comstock TL, Paterno MR, Ward KW. J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955 [Abstract] [Full Text] [Related]
15. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation. Gschwend MH, Martin W, Arnold P, Verdun MO, Cambon N, Frentzel A, Scheiwe W. Arzneimittelforschung; 2005 Aug; 55(7):403-13. PubMed ID: 16080280 [Abstract] [Full Text] [Related]
16. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. Proksch JW, Ward KW. J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. Chetoni P, Panichi L, Burgalassi S, Benelli U, Saettone MF. J Ocul Pharmacol Ther; 2000 Aug; 16(4):363-72. PubMed ID: 10977132 [Abstract] [Full Text] [Related]
19. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin. Manvelian G, Daniels S, Altman R. Postgrad Med; 2012 Jul; 124(4):197-205. PubMed ID: 22913908 [Abstract] [Full Text] [Related]
20. [The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits]. Fei WL, Chen JQ, Zhong SL, Liu YM, Pang ZQ, Wang Z, Yuan J, Ye CT. Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):305-8. PubMed ID: 16762205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]